|
AUC
|
P value
|
95% CI
|
Cut-off value
|
Sensitivity (%)
|
Specificity (%)
|
---|
Histopathological grade
|
SUVmax
|
0.711
|
0.0246
|
0.528 to 0.855
|
> 14.65
|
72.22
|
73.33
|
SUVmean
|
0.663
|
0.0963
|
0.478 to 0.817
|
> 7.12
|
77.78
|
53.33
|
MTV
|
0.796
|
0.0003
|
0.620 to 0.916
|
> 25.596
|
77.78
|
80
|
TLG
|
0.759
|
0.0025
|
0.579 to 0.890
|
> 192.653
|
77.78
|
66.67
|
Myometrial invasion
|
SUVmax
|
0.911
|
< 0.0001
|
0.759 to 0.982
|
> 14.55
|
88.89
|
86.67
|
SUVmean
|
0.852
|
< 0.0001
|
0.685 to 0.951
|
> 7.15
|
88.89
|
73.33
|
MTV
|
0.837
|
< 0.0001
|
0.667 to 0.942
|
> 25.596
|
77.78
|
80
|
TLG
|
0.911
|
< 0.0001
|
0.759 to 0.982
|
> 192.653
|
88.89
|
80
|
LVSI
|
SUVmax
|
0.848
|
< 0.0001
|
0.681 to 0.949
|
> 14.65
|
86.67
|
77.78
|
SUVmean
|
0.804
|
0.0002
|
0.629 to 0.921
|
> 9.15
|
66.67
|
88.89
|
MTV
|
0.848
|
< 0.0001
|
0.681 to 0.949
|
> 25.596
|
86.67
|
77.78
|
TLG
|
0.889
|
< 0.0001
|
0.731 to 0.971
|
> 179.374
|
100
|
66.67
|
LNMs
|
SUVmax
|
0.856
|
< 0.0001
|
0.691 to 0.954
|
> 18.34
|
77.78
|
87.50
|
SUVmean
|
0.861
|
< 0.0001
|
0.696 to 0.956
|
> 7.54
|
100
|
62.50
|
MTV
|
0.852
|
< 0.0001
|
0.685 to 0.951
|
> 30.125
|
88.89
|
79.17
|
TLG
|
0.921
|
< 0.0001
|
0.773 to 0.986
|
> 249.366
|
88.89
|
83.33
|
Risk stratification
|
SUVmax
|
0.839
|
< 0.0001
|
0.670 to 0.943
|
> 14.55
|
77.27
|
90.91
|
SUVmean
|
0.785
|
0.0007
|
0.608 to 0.908
|
> 7.12
|
81.82
|
72.73
|
MTV
|
0.826
|
< 0.0001
|
0.655 to 0.935
|
> 25.596
|
72.73
|
90.91
|
TLG
|
0.839
|
< 0.0001
|
0.670 to 0.943
|
> 192.653
|
77.27
|
81.82
|
- AUC, Area Under the Curve, LVSI, Lymph-vascular space invasion, LNMs, Lymph nodes metastases